XML 76 R96.htm IDEA: XBRL DOCUMENT v3.3.0.814

EMPLOYEE BENEFIT PLANS, ESTIMATED SUBSIDY PAYMENTS (Details) $ in Thousands	Sep. 30, 2015 USD ($)
Prescription Drug Subsidy Receipts, Fiscal Year Maturity [Abstract]
2016	$ 210
2017	231
2018	253
2019	276
2020	304
2021 - 2025	$ 2,067

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfExpectedGrossPrescriptionDrugSubsidyReceiptsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of the prescription drug subsidy receipts to be received after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsAfterYearFive
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of the prescription drug subsidy receipts to be received in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsNextTwelveMonths
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of the prescription drug subsidy receipts to be received in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsYearFive1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of the prescription drug subsidy receipts to be received in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsYearFour1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of the prescription drug subsidy receipts to be received in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsYearThree1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of the prescription drug subsidy receipts to be received in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 60



-Section 50



-Paragraph 4



-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 715



-SubTopic 20



-Section 50



-Paragraph 1



-Subparagraph (f)



-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name:	us-gaap_PrescriptionDrugSubsidyReceiptsYearTwo1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant